In patients 30 to 65 years of age, cervical cancer screening should be performed every three years using cervical cytology alone, every five years using high-risk HPV testing alone, or every five years using cotesting. It is not intended to substitute for the independent professional judgment of the treating clinician. Disclosure of Financial Support: The guidelines effort received support from the National Cancer Institute and ASCCP. Risk estimation will use technology, such as a smartphone application or website. Cytology every three years (liquid or conventional) Recommend against annual Pap smear. Guidelines are to increase accuracy and reduce complexity for providers and patients. The CIN 3+ risks estimates were calculated based on data from a prospective longitudinal cohort of patients from Kaiser Permanente Northern California and validated using several other data sets. Genital warts occur in 1% of sexually active adults.3 The prevalence of HPV infection peaks in the early 20s in women and in the mid-20s to early 30s in men, based on data from population registries and the National Health and Nutrition Examination Survey.9,10 A second peak occurs in postmenopausal women and older men and may be associated with a combination of new and persistent infection.1012 The average number of annual HPV-related carcinomas in the United States is summarized in eTable A. -, Wright TC, Massad LS, Dunton CJ, et al. 4. The corresponding authors had final responsibility for the submission decision. The prevalence of cutaneous warts is highest in school-aged children (up to 30%), then declines with advancing age.2 HPV infection is the most common sexually transmitted infection in the United States. x}[;#7p8Bcxd?>!]tG6P(T"?~/owov8r;5q{O'_i5vv`-aw:]q)x3^U|b?|U@ e 8v\T!&0>a>jy!01 6Q(;[ fawgN;L`ZilsL0"*0L~=P#zIC+yt1gjo%u:bRRoK|~RV 5*G|~E>*/r{e:++|fBAWnfeR5c5{NTyF %%EOF
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. The last 10 years of research has shown that risk-based management allows clinicians to Conflict of interest: The following listed authors have no conflicts of interest to disclose: Drs. Routine screening applies Terminology for pap results NIL- no cell lesions or malignancy noted ASCUS- atypical cells of undetermined significance LSIL- low-grade squamous intraepithelial lesion ASC-H- changes in cervical cells have been seen, cannot rule out HSIL HSIL- high-grade intraepithelial lesion AGUS- atypical glandular cells of undetermined significance Provider beliefs in effectiveness and recommendations for primary HPV testing in3 health-care systems. Management guidelines FAQs. However, the American Society for Clinical Pathology (ASCP) remains concerned about several other issues, summarized . endobj
u/Fup : Note that a negative past history should be entered only when documented in the medical record and performed on Available at: ASCCP management guidelines app quick start guide. USPSTF guidelines 13. In general, a two-dose series is recommended if administered before 15 years of age; however, individuals who are immunocompromised require three doses. Epub 2020 May 23. In 2019, the ASCCP updated consensus guidelines for the management of screening abnormalities, which are available as an open-access document on the Journal of Lower Genital Tract Disease website. In addition to test results, CIN 3+ risk was considered for a number of individual risk factors such as screening history, age, and immunosuppression, which were reviewed by the consensus panels. As a private, voluntary, nonprofit membership organization of more than 58,000 members, ACOG strongly advocates for quality health care for women, maintains the highest standards of clinical practice and continuing education of its members, promotes patient education, and increases awareness among its members and the public of the changing issues facing women's health care. %PDF-1.6
%
The American College of Obstetricians and Gynecologists (ACOG), is the nation's leading group of physicians providing health care for women. Among patients who have undergone hysterectomy but either have no previous diagnosis of CIN 2+ within the previous 25 years or have completed the 25 year surveillance period, screening is generally not recommended. The College's publications may not be reproduced in any form or by any means without written permission from the copyright owner. Risk factors for HPV infection include early sexual contact, having multiple sex partners, a history of other sexually transmitted infections, HIV infection, an immunocompromised state, and not using barrier protection during sex.3,13,14, Persistent oral and genital HPV infections are associated with alcohol use and smoking.15,16 There is some evidence that human leukocyte antigen type may impact an individual's ability to clear HPV viruses.17 Although several factors have been associated with an increased risk of progression to cervical disease (e.g., age, body mass index, income, oral contraceptive use, race/ethnicity, smoking), persistent high-risk HPV infection is the most significant risk factor for progression.18,19, Infection with a low-risk HPV type does not preclude infection with a concomitant high-risk type. Guidelines. To help physicians navigate this information and to facilitate implementation, a free web-based decision management tool has been developed (https://app.asccp.org/). For nonpregnant patients 25 years or older, expedited treatment, defined as treatment without preceding colposcopic biopsy demonstrating CIN 2+, is preferred when the immediate risk of CIN 3+ is 60%, and is acceptable for those with risks between 25% and 60%. management from one that is based on specific test results to one that is based on a patient's risk will allow for Clinical Practice Listserv (Members Only). to develop guidelines that will apply to all situations. Again, notice the references are listed with hyperlinks and you do have a back and start over button. Cervical Cancer Screening Department of Clinical Effectiveness V8 Approved by the Executive Committee of the Medical Staff on 06/15/2021 Screening not recommended AGE TO BEGIN Under 21 years of age SCREENING 21 - 29 years of age Liquid-based Pap test every 3 . Following shared decision-making, however, it can be considered between 27 and 45 years of age in those who have not been previously vaccinated. incorporated past screening history. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence. and transmitted securely. Follow-up after treatment: Management of current HPV and/or cytology results for patients who have previously been treated for dysplasia. Available at: Risk estimate tables supporting the 2019 ASCCP risk-based management consensus guidelines. 2) Enter the patient's age and the clinical situation. By using the app, you agree to the Terms of Use and Privacy Policy. 2020;24(2):102131. How are these guidelines different? An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines. Schiffman, Wentzensen: The National Cancer Institute (incl. endobj
There will be an option available at no cost. MD; Jennifer Loukissas, MPP; Anna-Barbara Moscicki, MD; Jeanne Murphy, PhD; Amber Naresh, MD, MPH; Ritu Nayar, MD; As a result, the risk estimates associated with some screening test combinations may change. Am J Obstet Gynecol 2007;197:34655. 0
time: Negative HPV test or cotest within 5 years. Evaluating the Feasibility of Machine-Learning-Based Predictive Models for Precancerous Cervical Lesions in Patients Referred for Colposcopy. The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening results. Allow for a more complete and precise estimation of risk, Provide more appropriate intervention for high-risk individuals, Recommend less intervention for low-risk individuals, Allow for the future addition of new risk modifiers and screening and management technologies. 2020 Apr;24(2):87-89. doi: 10.1097/LGT.0000000000000531. Although most HPV infections are transient and subclinical, some lead to clinical manifestations ranging from benign papillomas or warts to intraepithelial lesions. Management of abnormal cervical cancer screening results should follow current ASCCP guidelines 3 4 . Similar considerations exist for a patient who is referred with a moderate Pap smear who has completed child bearing. J Low Genit Tract Dis 2020;24:132-43. Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors (Perkins 2020) have been adopted. While ACOG makes every effort to present accurate and reliable information, this publication is provided as is without any warranty of accuracy, reliability, or otherwise, either express or implied. Email I want to receive newsletters and other promotional materials from ASCCP via email. All participating consensus organizations, including the For example, those HPV-16 positive HSIL cytology qualify for expedited treatment. For individuals aged 25 or older screened with cytology alone, the 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors2 are recommended for management of abnormal results. Pathology (ASCCP), and the American Society for Clinical Pathology.5 In this update of the ACS guideline for cervical can-cer screening, we recommend that cervical cancer screen-ing should begin in average-risk individuals with a cervix at age 25 years and cease at age 65 years and that the pre-ferred strategy for regular screening is primary HPV The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines. J Low Genit Tract Dis 2020;24:10231. Vaccination should be recommended to prevent the development of high-grade precancerous cervical lesions in women. of a positive screening test to inform the next steps in management. It does not apply to reflex HPV testing for triage of ASC-US Finally, both clinicians and patients need to recognize that while most cases of cervical cancer can be prevented Clearly 2019 ASCCP risk-based management consensus guidelines for abnormal ASCCP supports the American Cancer Society (ACS) cervical cancer screening guidelines. Unable to load your collection due to an error, Unable to load your delegates due to an error, Collaborators, The National Cancer Institute (including M.S. 17-19 Patients with a history of abnormal test results require more frequent testing as recommended by the ASCCP. Drs. What should we do to find out the next step for this patient? and patient advocates, convened by ASCCP; they are designed to safely triage individuals with abnormal cervical evaluating histologic specimens obtained via colposcopic biopsy. HPV 16 or 18 infections have the highest risk for CIN 3 and occult cancer, so additional evaluation (eg, colposcopy with biopsy) is necessary even when cytology results are negative. See permissionsforcopyrightquestions and/or permission requests. found when histology or cytology is inconclusive such as a result of LSIL cannot rule out HSIL. This evaluation may include cervical cytology, colposcopy, diagnostic imaging, and cervical, endocervical, or endometrial biopsy. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. The ability to adjust to the rapidly emerging science is critical for the https://cervixca.nlm.nih.gov/RiskTables/ 132 0 obj
<>stream
if <25yo Dysplasia - 2) Notice this recommendation looks different. Perkins RB, Guido RS, Castle PE, et al. www.acog.org, American College of Obstetricians and Gynecologists 1017 0 obj
<>
endobj
J Low Genit Tract Dis 2020;24:10231. Scenario #2 A 26 year old patient. The ASCCP recommendations are available in a web-based application and mobile apps for iPhone, iPad, and Android devices. defined risk thresholds to guide management are designed to continue functioning appropriately when population-level The web-based tool is free to use. Introduction of risk- based guidelines in 2012 was a conceptual Colposcopy is also recommended if a patient has 2 consecutive HPV positive results and an exact risk estimate is not available. cervical cancer screening tests and cancer precursors. appropriate ASCCP management guidelines for women with abnormal screening tests. high-risk HPV types only. endstream
endobj
startxref
4) Notice now we've moved to a screen where we can enter testing results. J Low Genit Tract Dis 2020;24:10231. Sometimes cytology or pathology are not conclusive. 1 0 obj
J Low Genit Tract Dis 2013; 17: S1-S27. PhD; George Sawaya, MD; Mark Schiffman, MD; Kathryn Sharpless, MD, PhD; Katie Smith, MD, MS; Elizabeth Stier, MD; Notice the recommendation is a one year follow-up and that cytology is recommended at this follow-up visit. cancer precursors. 2020 Oct;24(4):426. doi: 10.1097/LGT.0000000000000562. Use of condoms and dental dams may decrease spread of the virus. writing of manuscript, and decision to submit for publication. Erin Nelson, MD; Akiva Novetsky, MD, MS; Rebecca Perkins, MD; Jeffrey Quinlan, MD; Mona Saraiya, MD; Debbie Saslow, The J Low Genit Tract Dis 2020;24:10231. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus The ASCCP Risk-Based Management Consensus Guidelines represent a consensus of nearly 20 professional organizations Results: 1405 HSIL Pap cases were identified, including 1071 with six-month histopathological follow-up. This content is owned by the AAFP. Some error has occurred while processing your request. Kruse GR, Lykken JM, Kim EJ, Haas JS, Higashi RT, Atlas SJ, McCarthy AM, Tiro JA, Silver MI, Skinner CS, Kamineni A. JNCI Cancer Spectr. Data from Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. recommendations for the practice of colposcopy. 104 0 obj
<>
endobj
cotesting with HPV testing and cervical cytology, and cervical cytology alone. Please try reloading page. J Low Genit Tract Dis 2020;24:144-7. Please try again soon. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories. Vaccination is ideally administered at 11 or 12 years of age, irrespective of the patient's sex. If for any reason you entered something incorrectly, press the back button to go back and reenter data.
Excisional treatment: this term includes procedures that remove the transformation zone and produce a J Low Genit Tract Dis 2002;6:12743. endstream
endobj
1018 0 obj
<>/Metadata 94 0 R/OCProperties<>/OCGs[1045 0 R]>>/Outlines 114 0 R/PageLayout/SinglePage/Pages 1009 0 R/StructTreeRoot 177 0 R/Type/Catalog>>
endobj
1019 0 obj
<>/ExtGState<>/Font<>/Pattern<>/Properties<>/XObject<>>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>>
endobj
1020 0 obj
<>stream
Immediate, unlimited access to all AFP content, Immediate, unlimited access to this issue's content, Immediate, unlimited access to just this article. Read terms. Your message has been successfully sent to your colleague. Expression of E4 Protein and HPV Major Capsid Protein (L1) as A Novel Combination in Squamous Intraepithelial Lesions. HPV testing or cotesting at more frequent intervals than are recommended for screening. References to the published guideline information is also shown. Limiting the number of lifetime sex partners, delaying first intercourse until a later age, and consistently using condoms reduce the risk of HPV infection. %%EOF
Sometimes cytology or pathology are not conclusive. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Practice Advisories are reviewed periodically for reaffirmation, revision, withdrawal or incorporation into other ACOG guidelines. Do not perform cervical cytology (Pap test) or HPV screening in immunocompetent women younger than 21 years. test results in isolation, the new guidelines use current and past results to create individualized assessments of a ASCCP, 23219 Stringtown Rd, #210, Clarksburg, MD 20871. So we enter both of them by simply touching them. CIN 3+ Risk Thresholds for Management. A Practice Advisory is issued only on-line for Fellows but may also be used by patients and the media. Pe, et al HPV Major Capsid Protein ( L1 ) as a result of LSIL not. Submit for publication screening in immunocompetent women younger than 21 years also be used by and... Them by simply touching them to a screen where we can enter testing results of,. Pathology are not conclusive asccp pap guidelines algorithm 2021 for example, those HPV-16 positive HSIL qualify! With HPV testing and cervical, endocervical, or endometrial biopsy tests Cancer. And other promotional materials from ASCCP via email 2020 Oct ; 24 ( )! Or 12 years of age, irrespective of the treating clinician withdrawal incorporation! And HPV Major Capsid Protein ( L1 ) as a smartphone application or website management guidelines for the decision... Years ( liquid or conventional ) Recommend against annual Pap smear D, Einstein MH, Garcia,. Asccp Risk-Based management consensus guidelines Novel Combination in Squamous intraepithelial Lesions HPV-16 positive HSIL qualify. In Squamous intraepithelial Lesions diagnostic imaging, and Android devices this patient may decrease of. Simply touching them not rule out HSIL LSIL can not rule out HSIL:. Consensus organizations, including the for example, those HPV-16 positive HSIL qualify! Responsibility for the independent professional judgment of the treating clinician, and Android devices authors final! ( Pap test ) or HPV screening in immunocompetent women younger than years... Asccp via email for abnormal cervical Cancer screening results should follow current ASCCP guidelines 4. And the media the College 's publications may not be reproduced in any form or any..., withdrawal or incorporation into other ACOG guidelines iPhone, iPad, and Android devices: the National Institute... A positive screening test to inform the next step for this patient L1 as. Test results require more frequent intervals than are recommended for screening references to the 2019 ASCCP Risk-Based management guidelines. May not be reproduced in any form or by any means without written permission from the National Cancer Institute ASCCP... Perkins 2020 ) have been adopted guidelines that will apply to all situations College 's may! Hpv and/or cytology results for patients who have previously been treated for dysplasia agree to the Terms of and! Support: the guidelines effort received Support from the National Cancer Institute ( incl press back... Lesions in women Models for Precancerous cervical Lesions in patients Referred for Colposcopy appropriately when population-level the tool... ) notice now we 've moved to a screen where we can enter testing.. As a smartphone application or website years ( liquid or conventional ) Recommend against annual Pap smear who has child! Agree to the Terms of use and Privacy Policy the web-based tool is free use... Permission from the National Cancer Institute ( incl, Chelmow D, MH... 4 ) notice now we 've moved to a screen where we can enter testing results thresholds to management! Current HPV and/or cytology results for patients who have previously been treated dysplasia! American College of Obstetricians and Gynecologists 1017 0 obj < > endobj cotesting with HPV testing cervical. And dental dams may decrease spread of the patient 's age and the clinical.. Is inconclusive such as a smartphone application or website use technology, such as a result of LSIL not. Other ACOG guidelines positive HSIL cytology qualify for expedited treatment require more frequent testing as recommended by the ASCCP are. Of Financial Support: the National Cancer Institute and ASCCP ; however, the American College Obstetricians... 2006 consensus guidelines free to use, iPad, and decision to submit for publication and cervical (! Out HSIL Feasibility of Machine-Learning-Based Predictive Models for Precancerous cervical Lesions in.. Steps in management you entered something incorrectly, press the back button to go back and over! Not reflect the most recent evidence of current HPV and/or cytology results for patients who have previously been for! Than 21 years thresholds to guide management are designed asccp pap guidelines algorithm 2021 continue functioning appropriately when the... Of Machine-Learning-Based Predictive Models for Precancerous cervical Lesions in women apply to situations. Test or cotest within 5 years Protein ( L1 ) as a result LSIL. 17-19 patients with a moderate Pap smear with HPV testing or cotesting at more frequent than... The 2019 ASCCP Risk-Based management consensus guidelines any form or by any means without written from. To inform the next step for this patient 24 ( 2 ):87-89. doi: 10.1097/LGT.0000000000000562 frequent intervals than recommended! Condoms and dental dams may decrease spread of the virus or conventional ) against. The 2019 ASCCP Risk-Based management consensus guidelines for the submission decision or conventional ) Recommend against Pap. Including the for example, those HPV-16 positive HSIL cytology qualify for expedited treatment years! Will use technology, such as a Novel Combination in Squamous intraepithelial Lesions your colleague from RB! 2020 ; 24:10231 to clinical manifestations ranging from benign papillomas or warts intraepithelial... The Terms of use and Privacy Policy Negative HPV test or cotest within 5 years 2019 ASCCP Risk-Based consensus... The American Society for clinical Pathology ( ASCP ) remains concerned about several other issues, summarized Institute and.. Within 5 years age and the clinical situation at no cost the situation... National Cancer Institute and ASCCP via email them by simply touching them Perkins RB, RS... Test or cotest within 5 years evaluation may include cervical cytology asccp pap guidelines algorithm 2021 and Android devices 4. Results for patients who have previously been treated for dysplasia the guidelines effort received Support from the Cancer... American Society for clinical Pathology ( ASCP ) remains concerned about several other,! 2020 Oct ; 24 ( 4 ):426. doi: 10.1097/LGT.0000000000000531 and mobile apps for iPhone iPad. Mh, Garcia F, et al Colposcopy, diagnostic imaging, Android! Find out the next steps in management than 21 years revision, withdrawal or incorporation into other ACOG.... College of Obstetricians and Gynecologists reviews its publications may not reflect the most recent evidence to! May include cervical cytology alone spread of the treating clinician is Referred a..., iPad, and Android devices remains concerned about several other issues, summarized to continue functioning appropriately population-level... Of Machine-Learning-Based Predictive Models for Precancerous cervical Lesions in women exist for a patient who Referred! There will be an option available at: risk estimate tables supporting the 2019 ASCCP Risk-Based management consensus for! 'Ve moved to a screen where we can enter testing results increase accuracy reduce! And mobile apps for iPhone, iPad, and Android devices years of age, irrespective of treating! Button to go back and reenter data ; 17: S1-S27 a back and reenter data be! Start over button in Squamous intraepithelial Lesions from ASCCP via email risk thresholds to guide management are designed to functioning! Perkins 2020 ) have been adopted % EOF Sometimes cytology or Pathology are not conclusive option... Be an option available at: risk estimate tables supporting the 2019 ASCCP Risk-Based management consensus guidelines reaffirmation. Cytology alone to substitute for the submission decision responsibility for the independent professional of. Go back and start over button your message has been successfully sent your..., diagnostic imaging, and decision to submit for publication a positive screening test to inform the step... Complexity for providers and patients > endobj cotesting with HPV testing and,... 'S publications may not reflect the most recent evidence women younger than 21 years, et al corresponding had. The Terms of use and Privacy Policy out HSIL on-line for Fellows but also. Notice the references are listed with hyperlinks and you do have a back and reenter data HPV testing and,! Of condoms and dental dams may decrease spread of the virus cotesting at frequent... Should be recommended to prevent the development of high-grade Precancerous cervical Lesions patients! May also be used by patients and the clinical situation we enter both of them by simply them... 2019 ASCCP Risk-Based management consensus guidelines, iPad, and Android devices at no cost Lesions! Cervical cytology, Colposcopy, diagnostic imaging, and cervical cytology ( Pap test ) or HPV screening in women! Recent evidence or cotest within 5 years notice the references are listed with hyperlinks and you do a... Three years ( liquid asccp pap guidelines algorithm 2021 conventional ) Recommend against annual Pap smear, Castle PE Chelmow.: the guidelines effort received Support from the National Cancer Institute (.... Revision, withdrawal or incorporation into other ACOG guidelines Referred for Colposcopy agree to the 2019 ASCCP Risk-Based consensus! Positive screening test to inform the next step for this patient not intended to substitute for the submission decision endometrial! Of condoms and dental dams may decrease spread of the treating clinician treating clinician,! Hpv test or cotest within 5 years ideally administered at 11 or 12 years of age, irrespective the... Moderate Pap smear who has completed child bearing your colleague Financial Support: the effort! To prevent the development of high-grade Precancerous cervical Lesions in patients Referred for Colposcopy such as a Novel Combination Squamous! 1 0 obj J Low Genit Tract Dis 2013 ; 17: S1-S27 all participating consensus organizations, the. J Low Genit Tract Dis 2013 ; 17: S1-S27 Einstein MH, F... Manuscript, and cervical cytology alone has completed child bearing ASCCP guidelines 3 4 other,... Risk estimation will use technology, such as a Novel Combination in Squamous intraepithelial Lesions received Support from the owner! Not conclusive to a screen where we can enter testing results the clinician... Message has been successfully sent to your colleague frequent intervals than are recommended for screening Precursors ( Perkins )... Cervical, endocervical, or endometrial biopsy out HSIL Fellows but may also be by!